A human monoclonal antibody against small envelope protein of hepatitis B virus with potent neutralization effect

References

• Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immun 2015; 204:39-55; http://dx.doi.org/10.1007/s00430-014-0373-y
   PubMed Web of Science ®Google Scholar
• Liang X, Bi S, Yang W, Wang L, Cui G, Cui F, Zhang Y, Liu J, Gong X, Chen Y, et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 2009; 200:39-47; PMID:19469708; http://dx.doi.org/10.1086/599332
   PubMed Web of Science ®Google Scholar
• Ganem D, Prince AM. Hepatitis B virus infection–natural history and clinical consequences. N Engl J Med 2004; 350:1118-29; PMID:15014185; http://dx.doi.org/10.1056/NEJMra031087
   PubMed Web of Science ®Google Scholar
• Schulze A, Gripon P, Urban S. Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans. Hepatology 2007; 46:1759-68; PMID:18046710; http://dx.doi.org/10.1002/hep.21896
   PubMed Web of Science ®Google Scholar
• Leistner CM, Gruen-Bernhard S, Glebe D. Role of glycosaminoglycans for binding and infection of hepatitis B virus. Cell Microbiol 2008; 10:122-33; PMID:18086046; http://dx.doi.org/10.1111/j.1462-5822.2007.01023.x
   PubMed Web of Science ®Google Scholar
• Sureau C, Salisse J. A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant. Hepatology 2013; 57:985-94; PMID:23161433; http://dx.doi.org/10.1002/hep.26125
   PubMed Web of Science ®Google Scholar
• Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012; 1:e49; http://dx.doi.org/10.7554/eLife.00049
   PubMed Web of Science ®Google Scholar
• Ni Y, Lempp FA, Mehrle S, Nkongolo S, Kaufman C, Falth M, Stindt J, Koniger C, Nassal M, Kubitz R, et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology 2014; 146:1070-83; PMID:24361467; http://dx.doi.org/10.1053/j.gastro.2013.12.024
   PubMed Web of Science ®Google Scholar
• Neurath AR, Seto B, Strick N. Antibodies to synthetic peptides from the preS1 region of the hepatitis B virus (HBV) envelope (env) protein are virus-neutralizing and protective. Vaccine 1989; 7:234-6; PMID:2476893; http://dx.doi.org/10.1016/0264-410X(89)90235-1
   PubMed Web of Science ®Google Scholar
• Eren R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, Ben-Moshe O, Kitchinzky A, Berr S, Gopher J, et al. Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees. Hepatology 2000; 32:588-96; PMID:10960454; http://dx.doi.org/10.1053/jhep.2000.9632
   PubMed Web of Science ®Google Scholar
• Glebe D, Aliakbari M, Krass P, Knoop EV, Valerius KP, Gerlich WH. Pre-s1 antigen-dependent infection of Tupaia hepatocyte cultures with human hepatitis B virus. J Virol 2003; 77:9511-21; PMID:12915565; http://dx.doi.org/10.1128/JVI.77.17.9511-9521.2003
   PubMed Web of Science ®Google Scholar
• Andre FE, Zuckerman AJ. Review: protective efficacy of hepatitis B vaccines in neonates. J Med Virol 1994; 44:144-51; PMID:7852954; http://dx.doi.org/10.1002/jmv.1890440206
   PubMed Web of Science ®Google Scholar
• Ogata N, Ostberg L, Ehrlich PH, Wong DC, Miller RH, Purcell RH. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen. Proc Natl Acad Sci U S A 1993; 90:3014-8; PMID:8464917; http://dx.doi.org/10.1073/pnas.90.7.3014
   PubMed Web of Science ®Google Scholar
• Heijtink R, Paulij W, van Bergen P, van Roosmalen M, Rohm D, Eichentopf B, Muchmore E, de Man R, Osterhaus A. In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee. J Gen Virol 1999; 80 (Pt 6):1529-35; PMID:10374972; http://dx.doi.org/10.1099/0022-1317-80-6-1529
   PubMed Web of Science ®Google Scholar
• Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24:1-5; PMID:8707245; http://dx.doi.org/10.1002/hep.510240101
   PubMed Web of Science ®Google Scholar
• Dandri M, Burda MR, Torok E, Pollok JM, Iwanska A, Sommer G, Rogiers X, Rogler CE, Gupta S, Will H, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology 2001; 33:981-8; PMID:11283864; http://dx.doi.org/10.1053/jhep.2001.23314
   PubMed Web of Science ®Google Scholar
• Chisari FV, Pinkert CA, Milich DR, Filippi P, McLachlan A, Palmiter RD, Brinster RL. A transgenic mouse model of the chronic hepatitis B surface antigen carrier state. Science 1985; 230:1157-60; PMID:3865369; http://dx.doi.org/10.1126/science.3865369
   PubMed Web of Science ®Google Scholar
• Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. Infection of a human hepatoma cell line by hepatitis B virus. Proc Natl Acad Sci U S A 2002; 99:15655-60; PMID:12432097; http://dx.doi.org/10.1073/pnas.232137699
   PubMed Web of Science ®Google Scholar
• Chu CJ, Lok AS. Clinical significance of hepatitis B virus genotypes. Hepatology 2002; 35:1274-6; PMID:11981779; http://dx.doi.org/10.1053/jhep.2002.33161
   PubMed Web of Science ®Google Scholar
• Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004; 47:289-309; PMID:15564741; http://dx.doi.org/10.1159/000080872
   PubMed Web of Science ®Google Scholar
• Guo H, Jiang D, Zhou T, Cuconati A, Block TM, Guo JT. Characterization of the intracellular deproteinized relaxed circular DNA of hepatitis B virus: an intermediate of covalently closed circular DNA formation. J Virol 2007; 81:12472-84; PMID:17804499; http://dx.doi.org/10.1128/JVI.01123-07
   PubMed Web of Science ®Google Scholar
• Ren J, Wang L, Chen Z, Ma ZM, Zhu HG, Yang DL, Li XY, Wang BI, Fei J, Wang ZG, et al. Gene expression profile of transgenic mouse kidney reveals pathogenesis of hepatitis B virus associated nephropathy. J Med Virol 2006; 78:551-60; PMID:16555286; http://dx.doi.org/10.1002/jmv.20575
   PubMed Web of Science ®Google Scholar
• Zhao C, Fang CY, Tian XC, Wang L, Yang PY, Wen YM. Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. J Med Virol 2007; 79:1478-84; PMID:17705187; http://dx.doi.org/10.1002/jmv.20945
   PubMed Web of Science ®Google Scholar
• Dimitrov DS, Marks JD. Therapeutic antibodies: current state and future trends–is a paradigm change coming soon? Methods Mol Biol 2009; 525:1-27; PMID:19252861; http://dx.doi.org/10.1007/978-1-59745-554-1_1
   PubMedGoogle Scholar
• Casadevall A, Dadachova E, Pirofski LA. Passive antibody therapy for infectious diseases. Nat Rev Microbiol 2004; 2:695-703; PMID:15372080; http://dx.doi.org/10.1038/nrmicro974
   PubMed Web of Science ®Google Scholar
• Marasco WA, Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol 2007; 25:1421-34; PMID:18066039; http://dx.doi.org/10.1038/nbt1363
   PubMed Web of Science ®Google Scholar
• Schrama D, Reisfeld RA, Becker JC. Antibody targeted drugs as cancer therapeutics. Nat Rev Drug Discov 2006; 5:147-59; PMID:16424916; http://dx.doi.org/10.1038/nrd1957
   PubMed Web of Science ®Google Scholar
• Ryu CJ, Gripon P, Park HR, Park SS, Kim YK, Guguen-Guillouzo C, Yoo OJ, Hong HJ. In vitro neutralization of hepatitis B virus by monoclonal antibodies against the viral surface antigen. J Med Virol 1997; 52:226-33; PMID:9179773; http://dx.doi.org/10.1002/(SICI)1096-9071(199706)52:2%3c226::AID-JMV18%3e3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat Rev Immunol 2008; 8:34-47; PMID:18064051; http://dx.doi.org/10.1038/nri2206
   PubMed Web of Science ®Google Scholar
• Vogelpoel LT, Baeten DL, De Jong EC, Den Dunnen J. Control of cytokine production by human fc gamma receptors: implications for pathogen defense and autoimmunity. Front Immunol 2015; 6:79; PMID:25759693; http://dx.doi.org/10.3389/fimmu.2015.00079
   PubMed Web of Science ®Google Scholar
• Strohl WR. Optimization of Fc-mediated effector functions of monoclonal antibodies. Curr Opin Biotechnol 2009; 20:685-91; PMID:19896358; http://dx.doi.org/10.1016/j.copbio.2009.10.011
   PubMed Web of Science ®Google Scholar
• Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol 2006; 6:343-57; PMID:16622479; http://dx.doi.org/10.1038/nri1837
   PubMed Web of Science ®Google Scholar
• Kashyap AK, Steel J, Oner AF, Dillon MA, Swale RE, Wall KM, Perry KJ, Faynboym A, Ilhan M, Horowitz M, et al. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci U S A 2008; 105:5986-91; PMID:18413603; http://dx.doi.org/10.1073/pnas.0801367105
   PubMed Web of Science ®Google Scholar
• Sun L, Lu X, Li C, Wang M, Liu Q, Li Z, Hu X, Li J, Liu F, Li Q, et al. Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses. PLoS One 2009; 4:e5476; PMID:19421326; http://dx.doi.org/10.1371/journal.pone.0005476
   PubMed Web of Science ®Google Scholar
• Barbas CR, Kang AS, Lerner RA, Benkovic SJ. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc Natl Acad Sci U S A 1991; 88:7978-82; PMID:1896445; http://dx.doi.org/10.1073/pnas.88.18.7978
   PubMed Web of Science ®Google Scholar
• Barbas CR, Burton DR. Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol 1996; 14:230-4; PMID:8771795; http://dx.doi.org/10.1016/0167-7799(96)10029-9
   PubMed Web of Science ®Google Scholar
• Liang M, Dubel S, Li D, Queitsch I, Li W, Bautz EK. Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods 2001; 247:119-30; PMID:11150543; http://dx.doi.org/10.1016/S0022-1759(00)00322-7
   PubMed Web of Science ®Google Scholar